Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Stauber, RE; Stadlbauer, V.
Novel approaches for therapy of chronic hepatitis C.
J CLIN VIROL. 2006; 36(2): 87-94.
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Stadlbauer-Köllner Vanessa
Stauber Rudolf

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Currently available anti-HCV therapy is effective in only half of the patients and limited by side effects that often necessitate discontinuation. Therefore, new treatment strategies are being developed including (i) the optimization of current regimens, (ii) the use of additional agents working via novel mechanisms, and (iii) anti-fibrotic strategies. Many new antiviral compounds are now being studied in preclinical and clinical trials. This review will focus on drugs that have already entered the stage of phase 2 or phase 3 studies.
Find related publications in this database (using NLM MeSH Indexing)
Antidepressive Agents - therapeutic use
Antiviral Agents - therapeutic use
Clinical Trials as Topic -
Erythropoietin - therapeutic use
Genome, Viral -
Hepacivirus - drug effects Hepacivirus - genetics
Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - therapy
Humans -
Interferons - therapeutic use
Liver Cirrhosis - etiology Liver Cirrhosis - prevention and control
Protease Inhibitors - therapeutic use
Purine-Nucleoside Phosphorylase - antagonists and inhibitors Purine-Nucleoside Phosphorylase - chemistry Purine-Nucleoside Phosphorylase - therapeutic use
Pyrimidine Nucleosides - therapeutic use
Ribavirin - analogs and derivatives Ribavirin - chemistry Ribavirin - therapeutic use
Viral Hepatitis Vaccines - therapeutic use

Find related publications in this database (Keywords)
chronic hepatitis C
protease inhibitors
polymerase inhibitors
© Med Uni Graz Impressum